www.fdanews.com/articles/87668-novartis-pharma-obtains-additional-approval-for-its-proprietary-immunosuppressant-neoral
NOVARTIS PHARMA OBTAINS ADDITIONAL APPROVAL FOR ITS PROPRIETARY IMMUNOSUPPRESSANT NEORAL
June 19, 2006
Novartis Pharma has obtained additional approval for Neoral (cyclosporine), its proprietary immunosuppressant, from the Ministry of Health, Labor and Welfare.
JCN Network